ENVERIC BIOSCIENCES, INC. Payments for Repurchase of Redeemable Preferred Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- ENVERIC BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for the quarter ending 2023-12-31 was $0.00.
- ENVERIC BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for the quarter ending 2023-09-30 was $0.00.
- ENVERIC BIOSCIENCES, INC. payments for repurchase of redeemable preferred stock for fiscal 2023 was $1.05M.
| Period end | Payments for Repurchase of Redeemable Preferred Stock 3 month | Payments for Repurchase of Redeemable Preferred Stock 12 month |
|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $1.05M 10-K · filed 2025-03-28 |
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |